XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Fair Value of Options
The fair value of the stock options granted is estimated on the date of grant using a Black-Scholes option pricing model with the following weighted-average assumptions:
 Three Months Ended March 31,
 20212020
Expected stock price volatility66.7 %75.2 %
Risk free interest rate0.4 %1.7 %
Expected life of options (years)5.405.67
Expected annual dividend per share$— $— 
Schedule of Stock Options Activity
A summary of the Company's stock options for the three months ended March 31, 2021 were as follows:
Number of
Shares
Weighted Average Exercise 
Price
Weighted Average Remaining
Years
Aggregate
Intrinsic
Value
 (in thousands)  (in millions)
Options outstanding, December 31, 202014,032 $9.54   
Granted1,818 $21.46   
Exercised(493)$8.54   
Forfeited(273)$12.40   
Options outstanding, March 31, 202115,084 $10.96 6.7$18.5 
Vested and unvested expected to vest, March 31, 202113,643 $10.71 6.4$18.3 
Exercisable at March 31, 20218,962 $9.04 5.2$17.7 
Schedule of Non-Vested RSU Activity under the Plan A summary of non-vested RSU activity under the Plan for the three months ended March 31, 2021 is as follows:
Number of
Shares
Weighted
Average Grant
Date Fair
Value
Weighted 
Average
Remaining 
Years
Aggregate
Intrinsic
Value
(in thousands)(in millions)
Non-vested units as of December 31, 20207,080 $11.35   
Granted2,131 $20.22   
Vested(1,435)$17.38   
Forfeited(310)$13.36   
Non-vested units as of March 31, 20217,466 $14.14 2.7$73.8 
Schedule of Equity Compensation Expenses
The following table summarizes information related to compensation expense recognized in the Consolidated Statements of Operations related to the equity awards:
 Three Months Ended March 31,
(in thousands)20212020
Equity compensation expense recognized in:
Research and development expense$6,305 $5,253 
Selling, general, and administrative expense14,049 7,343 
Total equity compensation expense$20,354 $12,596